FDA recalls more than 2 million Ellume COVID-19 home tests
The Food and Drug Administration is recalling more than 2 million Ellume COVID-19 home tests because of its recent high false positive rate.
•
Nov 12, 2021, 12:02 PM
•
Updated 987 days ago
Share:
More Stories
0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
31ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
309ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
316ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds ago0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
31ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
309ds agoMurphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
316ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds agoThe Food and Drug Administration is recalling more than 2 million Ellume COVID-19 home tests because of its recent high false positive rate.
Regulators say false positives could lead to a delayed diagnosis or treatment of a person's actual illness.
The tests were said to be manufactured between Feb. 24 and Aug. 11 and distributed between April 13 to Aug. 26.
Millions of these at home COVID-19 tests are being pulled from store shelves.
